课题基金 / 基金详情

DETERMINANTS OF EPSTEIN BARR VIRUS MUCOSAL PATHOGENESIS

DETERMINANTS OF EPSTEIN BARR VIRUS MUCOSAL PATHOGENESIS
爱泼斯坦巴尔病毒粘膜发病的决定因素
批准号:
2458673
负责人:
JOHN W SIXBEY
金额:
$19.78万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-09-30 至 1998-07-31

项目摘要

项目成果

JOHN W SIXBEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The applicant proposes to determine the role of epithelial cell polarity in infection by EBV. Little is known about the early, molecular or otherwise, events in EBV infection, when a transient epithelial phase of infection is presumed to occur or what favors the appearance of epithelial diseases such as OHL, NPL or Burkitt's lymphoma associated with EBV. In preliminary results the applicant provides data to suggest that epithelial cell polarity may play a role, whether the uptake of EBV is mediated by the EBV receptor CR2 or by IgA modulation of infection. To address this issue the applicant has developed a MDCK cell line transformed with either (i) CDNA encoding the rabbit polymeric immunoglobulin receptor (pIgR) or (ii) CD21 (CR2) CDNA expression vector (PR4 CR2). These matched MDCK cell transformants will allow the investigators to follow the fate of EBV strains Bas.8 P3HR-1K and Akata following entry of epithelial cells by each pathway ie CR2 mediated or through IgA modulation. The investigators can examine the transcriptional program and fate of virion DNA as well as cell morphology and physiology via viral infection through both routes of entry. The investigators plan to determine whether EBV induces interleukin-10 (Il-10) in epithelial cells by ELISA, biological essays and eventually RT-PCR in collaboration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epstein-Barr Virus-Enhanced Tumor Progression
Epstein-Barr Virus-Enhanced Tumor Progression
Epstein-Barr Virus-Enhanced Tumor Progression
DETERMINANTS OF EPSTEIN BARR VIRUS MUCOSAL PATHOGENESIS
海外基金